Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
What's New at TheBody.com
  
  • Email Email
  • Glossary Glossary

 

For HIV Success, Ask the Transgender Community About Its Needs, Advises Panel

Barbara Jungwirth, TheBody.com; Posted Jun 24, 2:46 p.m. ET

Include trans people on advisory boards, identify and work with gatekeepers, conduct focus groups and use social media to find out what transgender people need. Then plan on meeting those needs, the panel concluded.

CDC Statement on National HIV Testing Day

Jonathan H. Mermin, M.D., M.P.H., and Eugene McCray, M.D., U.S. Centers for Disease Control and Prevention; Posted Jun 24, 11:19 a.m. ET

On June 27, HIV testing events will be occurring around the country. "By working to increase the number of persons who are aware of their HIV status, we will be one step closer to our goal of an AIDS-free generation," write Jonathan H. Mermin, M.D., M.P.H., and Eugene McCray, M.D.

HIV Among Issues Examined During White House's United State of Women Summit

Amy Lansky, Ph.D., and Caira Woods, Ph.D., White House; Posted Jun 24, 10:28 a.m. ET

Thousands of people recently gathered for the United State of Women, a White House summit focused on the needs of women and girls. Employing the theme, "Today, We'll Change Tomorrow," the event highlighted priorities such as health and wellness, violence against women, and economic empowerment.

This Week in HIV Research: Effects of Treatment on Arterial Inflammation; Mortality Rate After 5 Years of Treatment Not Impacted by Initial CD4 Count

Barbara Jungwirth, TheBodyPRO.com; Posted Jun 24, 9:58 a.m. ET

This week, a study examines the effects of antiretroviral therapy on arterial inflammation in people living with HIV. Another study finds while a higher CD4 count at treatment initiation is strongly associated with a lower mortality rate, that association essentially vanishes after five years on treatment.

Share Your Stories!

Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.

Day One With HIV: Finding Out Your Status, in Your Own Words

Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?


Other Sides of HIV: People Taking HIV Meds Share Stories About Side Effects

Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?

 

Serosorting Likely Responsible for Reducing HIV Infections in Seattle, Say Researchers

Emily Newman, BETA; Posted Jun 23, 4:34 p.m. ET

Over the last 12 years, more men who have sex with men in Seattle have been serosorting to reduce risk of HIV transmission, according to results from a study published in JAIDS. And it seems to be working -- with a corresponding decline in new HIV cases.

Watch the Webinar -- Policing HIV, Gender and Sexuality: Recent Data on Criminal Enforcement and Conditions of Confinement (Video)

Joshua Oaks, HIV Prevention Justice Alliance; Posted Jun 23, 3:40 p.m. ET

The LGBT/HIV Criminal Justice Working Group and HIV PJA collaborated on a webinar discussing how the policing of gender and sexuality pervades law enforcement, the operation of courts and the penal system, especially the policing of people living with HIV in the U.S.

Letter of Thanks From an HIV Advocate

The Center for HIV Law and Policy; Posted Jun 23, 3:18 p.m. ET

In a case in Ohio, a woman facing a term of imprisonment of two to eight years under Ohio's criminal HIV exposure and transmission statute was recently sentenced to a term of probation and HIV-related community service.

The First Generation to Age With HIV: Taking a Look at Long-Term Survival

Sherri Beachfront Lewis, TheBody.com; Posted Jun 23, 3:02 p.m. ET

Years ago, Sherri Lewis used a guided visualization of a long life as part of her HIV self-care. Still healthy, and cured of hepatitis C, she reflects on her journey and Desert Migration, a new long-term survivors' film.

My Health Tracker

My Health Tracker

My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.

Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.

 

ABT-493 + ABT-530 -- Eight-Week Treatment in Hepatitis C Genotypes 1 or 2 Without Cirrhosis

Sean R. Hosein, Canadian AIDS Treatment Information Exchange; Posted Jun 23, 2:47 p.m. ET

The combination of ABT-493 and ABT-530 was highly effective when taken for eight consecutive weeks in people with hepatitis C genotype 1 or 2 who did not have cirrhosis regardless of viral load and subtype.

ABT-493 + ABT-530 in Hepatitis C Genotype 3 With Cirrhosis

Sean R. Hosein, Canadian AIDS Treatment Information Exchange; Posted Jun 23, 2:47 p.m. ET

Twelve consecutive weeks of therapy with ABT-493 + ABT-530 was able to cure 100% of participants with hepatitis C genotype 3 and cirrhosis whether or not ribavirin was used.

When and How to Treat Depression -- and How to Make It Easier

Mark Mascolini, The Center for AIDS Information & Advocacy; Posted Jun 23, 2:46 p.m. ET

"Standard psychotherapeutic and pharmacological treatments work as well or better in achieving full remission from depression in HIV patients compared to the general population," according to Duke University depression expert Brian Pence and colleagues. Yet, research confirms that depression remains undiagnosed and untreated or poorly treated in people with HIV infection.

Depression Risk Factors With HIV -- Plus Screening and Diagnosis Keys

Mark Mascolini, The Center for AIDS Information & Advocacy; Posted Jun 23, 2:45 p.m. ET

Why is depression so prevalent in people with HIV infection? One inescapable reason is that depression ranks high among risk factors for HIV infection, so depression often precedes HIV infection and the two coexist after seroconversion.


>> Browse Older Featured Stories

 


  
  • Email Email
  • Glossary Glossary
Advertisement